Joshua Richardson serves as Executive at Sierra Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Joshua Richardson has executed 3 insider transactions totaling $4.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 2, 2022 involved purchasing 175,000 shares valued at $4.7M.
Joshua Richardson currently holds 175,000 shares of Sierra Oncology, Inc. (SRRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Richardson has been a net buyer of SRRA stock. They have purchased $4.7M and sold $0 worth of shares.
Joshua Richardson's most recent insider trade was on Feb 2, 2022, when they purchased 175,000 shares at $27.00 per share.
Get notified when new Form 4 filings are submitted
| $13.20 |
| Discretionary |
| Jan 29, 2020 | SRRA | $0 | Conversion | 1,477,320 | $N/A | Discretionary |